Big: Results from a large clinical trial in Africa showed that a twice-yearly injection of a new antiviral drug gave young women total protection from HIV
THIS IS HUGE! For the FIRST time, an HIV PrEP drug candidate in the form of a twice-yearly subcutaneous injection has shown ZERO infections in a late-stage Phase III trial. Lenacapavir was 100% effective at preventing HIV in MORE THAN 2,000 participants.
Let’s talk about that! 🧪🧵⬇️
“The results were so convincing that the trial was halted early at the recommendation of the independent data review committee”
They do this when the results are so overwhelming clear that it’s unethical to continue the trial with people getting inferior treatments.
